Uncategorised - European Medical Journal

Non-Diabetic Metabolic Dysfunction Increases Liver Fibrosis Risk

This study explored the effects of various metabolic abnormalities, such as central obesity, high blood pressure, and elevated high-sensitivity C-reactive protein (hsCRP), on liver steatosis and fibrosis.

Ceftazidime-Avibactam Resistance Emerges During Therapy

In a concerning development for infectious disease management, researchers have identified the emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae during the course of therapy, driven by novel mutations in KPC enzymes.

Healthy Lifestyle May Mitigate Telomere-Linked Brain Disease Risk

Healthy lifestyle choices could reduce the risk of stroke, dementia, and late-life depression in individuals with biologically shorter telomeres.

JAK Inhibitor Acne Common in Middle-Aged IBD

Acne has emerged as a frequent and clinically relevant side effect in patients with inflammatory bowel disease (IBD) treated with JAK inhibitors, according to the largest international retrospective cohort study to date on this adverse event.

ATS 2025 Interview: Raed Dweik

As a physician-scientist, studying the pulmonary circulation has given me the opportunity to align my clinical practice in…

ATS 2025 Interview: Jesse Roman

In my view, the best patient care enterprises are those that efficiently integrate research and education. In following the Flexnerian…

Lower Socioeconomic Status Linked to Hidradenitis Suppurativa

Compared to patients from the highest SES quintile, those in the lowest quintile had over three times the odds of being diagnosed with hidradenitis suppurativa.

New Monoclonal Antibody Cuts Bronchiolitis Admissions in Young Infants

Early evidence shows that nirsevimab substantially reduced emergency bronchiolitis cases and hospital admissions in infants under 6 months.

Updated Score Improves Prediction of COVID-19 Critical Care Demand

A simple forecasting tool for critical care demand has been updated to better reflect changing COVID-19 pandemic conditions.

Gαi3 Identified as Driver of Bladder Cancer Progression

A recent study identifies the Gαi3 protein as a key factor in bladder cancer progression. Researchers found that Gαi3 promotes tumour growth and survival by activating the Akt-mTOR pathway.